An Unusual Case of Metastatic Basal Cell Carcinoma of the Prostate: A Case Report and Literature Review
Conclusion: Our patient, diagnosed with recurrent prostate BCC after receiving a radical prostatectomy, responded to treatment with etoposide. Radical prostatectomy and radiotherapy should remain first-line therapy; however, etoposide may be an alternative second-line therapy when other options are not available. Consensus regarding treatment plans, and the molecular mechanisms behind prostate BBC, must be elucidated.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Ataxia | Basal Cell Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | CT Scan | Docetaxel | Genetics | PET Scan | Prostate Cancer | Prostatectomy | Seminoma | Skin Cancer | Taxotere | Testicular Cancer